Daily Archives: Junho 3, 2021 | LinksMedicus Free Medical News & Perspectives

Países mais atingidos pela COVID-19 – A mortalidade estimada para 1/9/2021.

3 Jun, 2021 | 10:09h

Countries Hit Hardest by COVID-19 – Think Global Health

Comentário no Twitter (fio – clique para saber mais)

❓🌎🌍🌏 Which countries will have the highest mortality from COVID-19 come September 1, 2021? IHME researchers ran the numbers for a new article in @ThinkGlobalHlth ⤵️🧵https://t.co/d2CFHVzCYX

— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) June 2, 2021

Estudo de coorte mostrou boa recuperação na maioria das crianças 6 meses após síndrome multissistêmica inflamatória pediátrica (pediatric inflammatory multisystem syndrome – PIMS-TS) associada ao SARS-CoV-2.

3 Jun, 2021 | 10:07h

6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study – The Lancet Child & Adolescent Health

Comentário: Most severe effects of MIS-C in children typically resolve within six months, new research suggests – CNN E Children who developed a rare inflammation disease after COVID-19 are mostly better after 6 months, but some still suffer fatigue and anxiety, a small UK study found – Insider E Most severe effects of PIMS-TS resolved at six months – HealthDay

Comentário no Twitter

New Research—A study of 46 patients with #PIMSTS found that most symptoms were resolved after 6 months, but fatigue, difficulty exercising, and emotional difficulties persisted in some childrenhttps://t.co/mHz3D8a11d #COVID19 @GreatOrmondSt @KarynMoshal pic.twitter.com/PJCxGGmJNo

— The Lancet Child & Adolescent Health (@LancetChildAdol) May 24, 2021

O que se sabe sobre a perigosa variante B.1.617.2 (Delta) da COVID – “A variante Delta pode, em breve, se tornar a cepa dominante de COVID no mundo e levar a surtos rápidos nos países sem altos índices de vacinação.”

3 Jun, 2021 | 10:05h

What We Know About the Dangerous COVID B.1.617.2 (Delta) Variant – Intelligencer

Comentário no Twitter

Good summary of what's presently known about the B.1.617.2 (Delta) variant @NYMag. Important to emphasize 2-dose vaccination effectiveness is high.https://t.co/8cKvR5eBMM w/ @jburnmurdoch @zeynep @macroliter by @chasdanner

— Eric Topol (@EricTopol) June 1, 2021

Monitoramento da vacinação contra o coronavírus pelo mundo.

3 Jun, 2021 | 10:03h

Tracking Coronavirus Vaccinations Around the World – The New York Times

Experimento em cidade brasileira mostra que a vacinação em massa pode dissipar a COVID-19.

3 Jun, 2021 | 10:02h

Brazilian town experiment shows mass vaccination can wipe out COVID-19 – Science (poucos artigos gratuitos por mês)

Relacionado: [Press release – not published yet] The city of Serrana in Brazil has seen a 95% drop in Covid-19 deaths after almost all adults were vaccinated with Chinese CoronaVac – The findings suggest the pandemic can be controlled after 75% of people are fully vaccinated.

Lado positivo da pandemia: o vírus da gripe se tornou menos diverso, simplificando a tarefa de produzir vacinas.

3 Jun, 2021 | 10:01h

A pandemic upside: The flu virus became less diverse, simplifying the task of making flu shots – STAT

Estudo randomizado: Em pacientes com diabetes tipo 2 tratados com insulina basal e com controle glicêmico ruim (média de HbA1c = 9,1%), o monitoramento contínuo da glicose (MCG) reduziu o nível de HbA1c em 0,4%, em comparação com o cuidado usual (8% e 8,4%). O envolvimento do paciente (i.e., adesão, dieta, atividade física em resposta às leituras do MCG) foi o motivo mais provável de melhora no controle glicêmico.

3 Jun, 2021 | 10:00h

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial – JAMA

Editorial: Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes – JAMA

Comentário: Studies support wider CGM access in type 2 diabetes – medwire News

Comentário no Twitter

Continuous glucose monitoring resulted in better glycemic control compared with blood glucose meter monitoring in adults with poorly controlled type 2 diabetes treated with basal insulin without prandial insulin https://t.co/D0y7B8JsJE

— JAMA (@JAMA_current) June 2, 2021